BANK OF MONTREAL /CAN/ - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 199 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$2,692,000
+585.0%
58,920
+960.1%
0.00%
Q1 2022$393,000
+7.4%
5,558
+14.2%
0.00%
Q4 2021$366,000
+4.6%
4,868
-20.9%
0.00%
Q3 2021$350,000
+10.1%
6,155
-6.3%
0.00%
Q2 2021$318,000
+32.0%
6,570
+33.8%
0.00%
Q1 2021$241,000
-3.2%
4,909
-4.2%
0.00%
Q4 2020$249,000
+170.7%
5,126
+164.0%
0.00%
Q3 2020$92,000
-21.4%
1,942
-15.6%
0.00%
Q2 2020$117,000
+290.0%
2,301
+288.0%
0.00%
Q1 2020$30,000
-81.6%
593
-77.6%
0.00%
Q4 2019$163,000
+30.4%
2,642
+26.2%
0.00%
Q3 2019$125,000
-35.6%
2,094
-9.0%
0.00%
Q2 2019$194,000
+162.2%
2,300
+198.3%
0.00%
Q1 2019$74,000
+21.3%
771
-11.4%
0.00%
Q4 2018$61,000
+8.9%
870
+33.0%
0.00%
Q3 2018$56,000
-97.6%
654
-96.7%
0.00%
-100.0%
Q2 2018$2,328,000
+6.5%
20,082
-25.6%
0.00%0.0%
Q1 2018$2,185,000
-5.9%
27,007
-31.7%
0.00%0.0%
Q4 2017$2,322,000
+40.7%
39,562
+12.2%
0.00%0.0%
Q3 2017$1,650,000
+1583.7%
35,256
+994.6%
0.00%
Q1 2017$98,000
-15.5%
3,221
-12.6%
0.00%
Q4 2016$116,000
+48.7%
3,684
+24.8%
0.00%
Q3 2016$78,000
+212.0%
2,952
+243.7%
0.00%
Q1 2016$25,000
-69.9%
859
-62.6%
0.00%
Q3 2015$83,000
+2666.7%
2,296
+2539.1%
0.00%
Q1 2015$3,000
-25.0%
87
-3.3%
0.00%
Q2 2014$4,000900.00%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 862,848$42,556,00014.73%
Fairmount Funds Management LLC 171,147$8,441,0003.56%
ARMISTICE CAPITAL, LLC 1,648,000$81,279,0001.87%
FARALLON CAPITAL MANAGEMENT LLC 1,995,000$98,393,0000.49%
Jackson Creek Investment Advisors LLC 21,409$1,056,0000.37%
Hennion & Walsh Asset Management, Inc. 113,940$5,620,0000.34%
Virtus ETF Advisers LLC 14,721$726,0000.31%
Granahan Investment Management 193,416$9,539,0000.20%
Yorktown Management & Research Co Inc 4,500$222,0000.18%
JACOBS LEVY EQUITY MANAGEMENT, INC 242,257$11,948,0000.09%
View complete list of ENANTA PHARMACEUTICALS INC shareholders